Phompradit Papichaya, Chaijaroenkul Wanna, Na-Bangchang Kesara
Thammasat University Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Rangsit Campus, Pathumthani, 12121, Thailand.
Parasitol Res. 2017 Dec;116(12):3331-3339. doi: 10.1007/s00436-017-5647-z. Epub 2017 Nov 10.
The recent reports of high failure rates and decline in in vitro sensitivity of Plasmodium falciparum to artemisinin-based combination therapies (ACTs) suggest the possibility of clinical artemisinin resistance along the Thai-Cambodian and Thai-Myanmar borders. The study investigated cellular mechanisms of action and resistance of P. falciparum to artesunate (stage specific activity, interaction with hemozoin, and anti-oxidant levels) in the two paired P. falciparum isolates (MSF046 and MSF060) collected before treatment with a 3-day artesunate-mefloquine and at the time of recrudescence. In addition, the link of these cellular mechanisms to the polymorphisms of the candidate artemisinin-resistant genes (pfatp6, pfcrt, pfmdr1, pfmrp1, and K13 propeller) was also investigated. Morphological change was observed in both pairs of the primary and recrudesced P. falciparum isolates during 12-48 h of exposure to artesunate (at IC). A marked decrease in parasite viability was found in the recrudesced isolates of both MSF046 and MSD060. The extent of the reduction (% change of baseline) in total glutathione concentrations was significantly lower in recrudesced (32.1 and 1.7%) compared with primary (45.5 and 53.7%) isolates of both MSF046 and MSF060. The extent of reduction of hemozoin content in MSF046 was significantly higher in the recrudesced (76.8%) isolate compared with the primary isolate (99.5%). For MSF060 on the other hand, increase in hemozoin content was found in the recrudesced isolate and the extent of such increase was significantly higher in recrudesced (93.1%) than the primary isolate (87.5%). Polymorphism of K13 (N458Y) together with pfmdr1 copy number correlated well with sensitivity of both isolates to artesunate. Results of this preliminary study suggests possible role of glutathione-dependent detoxification system as well as heme degradation as cellular mechanisms of action and resistance of artemisinins.
近期有报道称恶性疟原虫对青蒿素联合疗法(ACTs)的体外敏感性出现高失败率及下降情况,这表明在泰国与柬埔寨边境以及泰国与缅甸边境可能存在临床青蒿素耐药性。该研究调查了在接受为期3天的青蒿琥酯-甲氟喹治疗前及复发时收集的两对恶性疟原虫分离株(MSF046和MSF060)中,恶性疟原虫对青蒿琥酯的细胞作用机制及耐药性(阶段特异性活性、与疟原虫色素的相互作用以及抗氧化水平)。此外,还研究了这些细胞机制与候选青蒿素耐药基因(pfatp6、pfcrt、pfmdr1、pfmrp1和K13螺旋桨)多态性之间的联系。在暴露于青蒿琥酯(在IC浓度)12至48小时期间,在两对原发性和复发性恶性疟原虫分离株中均观察到形态变化。在MSF046和MSD060的复发性分离株中均发现寄生虫活力显著下降。与MSF046和MSF060的原发性分离株(分别为45.5%和53.7%)相比,复发性分离株(分别为32.1%和1.7%)中总谷胱甘肽浓度的降低程度(相对于基线变化百分比)显著更低。与原发性分离株(99.5%)相比,MSF046复发性分离株(76.8%)中疟原虫色素含量的降低程度显著更高。另一方面,对于MSF060,在复发性分离株中发现疟原虫色素含量增加,且这种增加程度在复发性分离株(93.1%)中显著高于原发性分离株(87.5%)。K13(N458Y)的多态性以及pfmdr1拷贝数与这两种分离株对青蒿琥酯的敏感性密切相关。这项初步研究的结果表明,谷胱甘肽依赖性解毒系统以及血红素降解可能作为青蒿素的细胞作用机制和耐药机制发挥作用。